New York, USA – April 21, 2021 – Since the outbreak of COVID-19 and other infectious epidemics, the vaccine center at Creative Biolabs keeps under high-tensity operation in that the inquiries & orders regarding vaccine development are mounting. As a professional service provider in the vaccine industry with years of experience and skillful scientific staff, Creative Biolabs has been providing first-level services and high-standard products, meanwhile extending their service capabilities, which, by now, has the competence to support the vaccine R&D and assist with the pre-clinical manufacturing of vaccine candidates.
Vaccine Design & Development Strategies
Creative Biolabs is quite skillful at the design of both prophylactic and therapeutic vaccines, including DC vaccine, subunit vaccine, mAb vaccine, and DNA or RNA vaccine, covering multiple research targets like fungal, HBV, HPV, and HIV. Creative Biolabs optimizes the vaccine not only using stable liquid formulation and lyophilized formulation but also in terms of adjuvant, delivery system, and other excipients. A vaccine candidate must go through exhaustive pre-clinical evaluations before it can enter the clinical stage. Creative Biolabs provides both in vitro and in vivo tests to ensure the vaccine candidate is qualified in purity, potency, stability, and most important of all, safety.
If requested, Creative Biolabs also assists with the commercialization process of a vaccine candidate through the process development & GMP manufacturing solution.
Cancer vaccine capabilities-Next-CV™ Cancer Vaccine Programs
Against both solid tumor in tissues and non-solid tumor such as hematological malignancy, there are corresponding solutions at Creative Biolabs, which are offered by seasoned scientists utilizing high-end vaccine technologies like tumor-APC fusion technology, immune monitoring assays, and immunological checkpoint therapy, and all initiate from antigen formulation selection & optimization, revolutionizing the traditional cancer development strategies.
“Recently we received a good number of orders regarding antigen products,” according to a scientist from the vaccine sector. In addition to the services, the chemicals necessary for vaccine development are also supplied by Creative Biolabs, like adjuvants and cell culture media, which are in full inventory and readily available for global shipment. Explore more details at https://www.creative-biolabs.com/vaccine.
Creative Biolabs is a professional biotechnology service provider in the area of vaccine development, pre-clinical assessment, and GMP manufacturing. Combining the classical and up-to-date technologies, Creative Biolabs can help produce highly immunogenic and safe vaccines for research use. A custom-service-centered business model is adopted to optimize the vaccine development process, leverage accessible resources, and gather a team from various backgrounds to conduct vaccine development projects cost-effectively.